Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
63.76
-1.80 (-2.75%)
At close: Oct 10, 2025, 4:00 PM EDT
62.48
-1.28 (-2.00%)
After-hours: Oct 10, 2025, 7:42 PM EDT

Soleno Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202013 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2013 - 2019
Selling, General & Admin
-105.8613.489.8410.818.76
Upgrade
Research & Development
74.2978.5725.1915.2721.4523.19
Upgrade
Other Operating Expenses
-5.27-3.24-2.710.710.73-4.34
Upgrade
Total Operating Expenses
69.02181.1935.9625.8232.9927.61
Upgrade
Operating Income
-191.6-187.67-41.38-24.4-31.53-36.29
Upgrade
Interest Income
----0.110.01
Upgrade
Interest Expense
--0.23----
Upgrade
Other Non-Operating Income (Expense)
13.4912.052.40.330.5111.64
Upgrade
Total Non-Operating Income (Expense)
13.4911.822.40.330.6211.65
Upgrade
Pretax Income
-178.11-175.85-38.99-24.07-30.91-24.64
Upgrade
Net Income
-181.08-175.85-38.99-24.07-30.91-24.64
Upgrade
Net Income to Common
-181.08-175.85-38.99-24.07-30.91-24.64
Upgrade
Shares Outstanding (Basic)
464016854
Upgrade
Shares Outstanding (Diluted)
464016854
Upgrade
Shares Change (YoY)
51.15%143.61%96.40%57.90%27.39%83.41%
Upgrade
EPS (Basic)
-4.14-4.38-2.36-2.87-5.81-5.85
Upgrade
EPS (Diluted)
-4.14-4.38-2.36-2.87-5.81-5.85
Upgrade
Free Cash Flow
-84.49-69.31-24.94-20.79-27.79-25.23
Upgrade
Free Cash Flow Per Share
-1.85-1.73-1.51-2.48-5.23-6.04
Upgrade
EBITDA
-189.59-185.68-39.43-22.43-29.57-34.34
Upgrade
EBIT
-191.6-187.67-41.38-24.4-31.53-36.29
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q